Top compounds associated with response to LYPD6


Feature Type Standardized
Nominal ANOVA
mRNA necrostatin-7 CTRPv2 pan-cancer AAC -0.033 0.4
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA QW-BI-011 CTRPv2 pan-cancer AAC 0.059 0.4
mRNA CI-976 CTRPv2 pan-cancer AAC -0.034 0.4
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC -0.057 0.4
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.032 0.4
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.043 0.4
mRNA SKI-II CTRPv2 pan-cancer AAC -0.031 0.4
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC -0.032 0.4
Download CSV